PCR Innovators Day 2026: innovation in action

Where ideas, technologies and conversations moved cardiovascular innovation closer to practice

PCR Innovators Day

#PCRID 2026 explored what’s next in cardiovascular innovation, from AI and first-in-human technologies to disruptive transcatheter therapies, venture capital perspectives and heart failure innovation. Revisit the discussions, innovations and key statistics from this year’s edition in Paris. 

✨ Key figures of this 2026 edition

  • 1-day Course at the Palais des Congrès in Paris
  • 500+ participants
  • 76 Faculty
  • 26 Presenters
  • 21 sessions
  • 1 Jon DeHaan Foundation Awardee received $200,000
  • 8 Innovator's Exchange Hubs

See what shaped the 2026 Programme

From AI and heart failure innovation to rapid-fire sessions and Innovators Exchange Hubs, revisit the discussions, technologies and ideas that shaped #PCRID.

VIEW THE PROGRAMME

Explore the Innovations Book

Access the innovations accepted for presentation at PCR Innovators Day 2026 and stay up to date with the ideas, technologies and projects shaping tomorrow’s practice.

OPEN THE BOOK

Share your opinion!

What did you like best; what could have been enhanced? PCR Innovators Day is built by and for the community and your feedback will help shape future editions.

TAKE SURVEY

Bringing the innovation ecosystem together in 2026

At #PCRID 2026, innovation didn’t happen from a single perspective. Explore the ecosystem connecting physicians, startups, investors, industry leaders and strategic experts working to move ideas towards clinical reality.

MEET THE ECOSYSTEM

 

⭐ The 2026 Jon DeHaan Foundation Award winner

Congratulations to Susheel Kodali (United States), winner of the 2026 Jon DeHaan Foundation Award supporting cardiovascular innovation. He was awarded a $200,000 grant to further his work on the first-in-human treatment of functional mitral regurgitation with the CARLEN System.

Did you attend PCR Innovators Day? See if you can spot yourself ⬇️

Sign up for the newsletter

 By entering your e-mail address, you agree to receive e-communication from us and acknowledge that you have read our Privacy Policy